{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:09:36Z","timestamp":1768511376397,"version":"3.49.0"},"posted":{"date-parts":[[2024,5,9]]},"group-title":"Developmental Biology","reference-count":25,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Fibroblast growth factor receptor 4 (FGFR4) has a role in many biological processes, including lipid metabolism, tissue repair, and vertebrate development. In recent years, FGFR4 overexpression and activating mutations have been associated with numerous adult and pediatric cancers. As such,\n                  <jats:italic>FGFR4<\/jats:italic>\n                  presents an opportunity for therapeutic targeting which is being pursued in clinical trials. To understand the role of FGFR4 signaling in disease and development, we generated and characterized three alleles of\n                  <jats:italic>fgfr4<\/jats:italic>\n                  knockout zebrafish strains using CRISPR\/Cas9. To generate\n                  <jats:italic>fgfr4<\/jats:italic>\n                  knockout crispants, we injected single-cell wildtype zebrafish embryos with\n                  <jats:italic>fgfr4<\/jats:italic>\n                  targeting guide RNA and Cas9 proteins, identified adult founders, and outcrossed to wildtype zebrafish to create an F1 generation. The generated mutations introduce a stop codon within the second Ig-like domain of Fgfr4, resulting in a truncated 215, 223, or 228 amino acid Fgfr4 protein compared to 922 amino acids in the full-length protein. All mutant strains exhibited significantly decreased\n                  <jats:italic>fgfr4<\/jats:italic>\n                  mRNA expression during development, providing evidence for successful knockout of\n                  <jats:italic>fgfr4<\/jats:italic>\n                  in mutant zebrafish. We found that, consistent with other\n                  <jats:italic>Fgfr4<\/jats:italic>\n                  knockout animal models, the\n                  <jats:italic>fgfr4<\/jats:italic>\n                  mutant fish developed normally; however, homozygous\n                  <jats:italic>fgfr4<\/jats:italic>\n                  mutant zebrafish were significantly smaller than wildtype fish at three months post fertilization. These\n                  <jats:italic>fgfr4<\/jats:italic>\n                  knockout zebrafish lines are a valuable tool to study the role of FGFR4 in vertebrate development and its viability as a potential therapeutic target in pediatric and adult cancers, as well as other diseases.\n                <\/jats:p>","DOI":"10.1101\/2024.05.08.593184","type":"posted-content","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T23:20:18Z","timestamp":1715296818000},"source":"Crossref","is-referenced-by-count":0,"title":["Engineering an\n                  <i>fgfr4<\/i>\n                  knockout zebrafish to study its role in development and disease"],"prefix":"10.64898","author":[{"given":"Emma N.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda N.","family":"Jay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-8714","authenticated-orcid":false,"given":"Matthew R.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia P.","family":"Sukienik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collette A.","family":"LaVigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3775-2006","authenticated-orcid":false,"given":"Genevieve C.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"1","key":"2024051400450486000_2024.05.08.593184v1.1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2024051400450486000_2024.05.08.593184v1.2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507440200"},{"issue":"19","key":"2024051400450486000_2024.05.08.593184v1.3","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1242\/dev.129.19.4559","article-title":"FGFR4 signaling is a necessary step in limb muscle differentiation","volume":"129","year":"2002","journal-title":"Development"},{"issue":"10","key":"2024051400450486000_2024.05.08.593184v1.4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.5858\/2006-130-1454-RIAACA","article-title":"Rhabdomyosarcomas in adults and children: an update","volume":"130","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2024051400450486000_2024.05.08.593184v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0066-3"},{"key":"2024051400450486000_2024.05.08.593184v1.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5591"},{"key":"2024051400450486000_2024.05.08.593184v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24532"},{"key":"2024051400450486000_2024.05.08.593184v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/ng0293-113"},{"key":"2024051400450486000_2024.05.08.593184v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/ng1193-230"},{"issue":"21","key":"2024051400450486000_2024.05.08.593184v1.10","first-page":"5108","article-title":"Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma","volume":"53","year":"1993","journal-title":"Cancer Res"},{"issue":"11","key":"2024051400450486000_2024.05.08.593184v1.11","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","year":"2009","journal-title":"J Clin Invest"},{"key":"2024051400450486000_2024.05.08.593184v1.12","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20848"},{"key":"2024051400450486000_2024.05.08.593184v1.13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0582"},{"key":"2024051400450486000_2024.05.08.593184v1.14","doi-asserted-by":"publisher","DOI":"10.1101\/gad.477908"},{"key":"2024051400450486000_2024.05.08.593184v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01157-0"},{"issue":"10","key":"2024051400450486000_2024.05.08.593184v1.16","doi-asserted-by":"crossref","first-page":"101204","DOI":"10.1016\/j.xcrm.2023.101204","article-title":"Clinical development and management of adverse events associated with FGFR inhibitors","volume":"4","year":"2023","journal-title":"Cell Rep Med"},{"key":"2024051400450486000_2024.05.08.593184v1.17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcell.2020.00095","article-title":"Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression","volume":"8","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"2024051400450486000_2024.05.08.593184v1.18","doi-asserted-by":"crossref","first-page":"101212","DOI":"10.1016\/j.xcrm.2023.101212","article-title":"Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma","volume":"4","year":"2023","journal-title":"Cell Rep Med"},{"key":"2024051400450486000_2024.05.08.593184v1.19","doi-asserted-by":"publisher","DOI":"10.1089\/zeb.2014.1047"},{"key":"2024051400450486000_2024.05.08.593184v1.20","doi-asserted-by":"crossref","unstructured":"Silvius KM , Kendall GC . A Robust Closed-Tube Method for Resolving tp53(M214K) Genotypes. Zebrafish. 2024.","DOI":"10.1089\/zeb.2023.0030"},{"key":"2024051400450486000_2024.05.08.593184v1.21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3771-4"},{"key":"2024051400450486000_2024.05.08.593184v1.22","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.119.302345"},{"issue":"18","key":"2024051400450486000_2024.05.08.593184v1.23","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1242\/dev.125.18.3615","article-title":"FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung","volume":"125","year":"1998","journal-title":"Development"},{"key":"2024051400450486000_2024.05.08.593184v1.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.20.15482"},{"key":"2024051400450486000_2024.05.08.593184v1.25","doi-asserted-by":"crossref","unstructured":"Kendall GC , Watson S , Xu L , LaVigne CA , Murchison W , Rakheja D , et al. PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis. Elife. 2018;7.","DOI":"10.7554\/eLife.33800"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.08.593184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:25:08Z","timestamp":1768458308000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.05.08.593184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1101\/2024.05.08.593184","relation":{},"subject":[],"published":{"date-parts":[[2024,5,9]]},"subtype":"preprint"}}